Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management

Aim. To evaluate the efficacy and safety of the novel combined laser treatment technology compared with those of the conventional laser photocoagulation in diabetic macular oedema management. Material and methods. Fifty eyes of 44 patients with clinically significant diabetic macular oedema were en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksander Victorovich Doga, Galina Fedorovna Kachalina, Elena Konstantinovna Pedanova, Dmitry Anatolievich Buryakov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/ddec57eac97a47c58a35e8caabf57d19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ddec57eac97a47c58a35e8caabf57d19
record_format dspace
spelling oai:doaj.org-article:ddec57eac97a47c58a35e8caabf57d192021-11-14T09:00:21ZComparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management2072-03512072-037810.14341/DM7811https://doaj.org/article/ddec57eac97a47c58a35e8caabf57d192017-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7811https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To evaluate the efficacy and safety of the novel combined laser treatment technology compared with those of the conventional laser photocoagulation in diabetic macular oedema management. Material and methods. Fifty eyes of 44 patients with clinically significant diabetic macular oedema were enrolled. Patients of the main group (25 eyes) underwent combined laser treatment, whereas patients in the control group (25 eyes) underwent modified ETDRS (mETDRS) focal/grid photocoagulation. Results. Mean central point thickness (CPT) in the main group decreased from 411.24 ± 126 µm to 359.86 ± 120.4 µm (p < 0.05), with a subsequent increase in the mean best-corrected visual acuity (BCVA) from 0.52 ± 0.2 at baseline to 0.71 ± 0.2 (p < 0.05) at the 12-month follow-up. The mean central retinal sensitivity (RS) improved from 11.27 ± 3.8 dB to 13.24 ± 3.2 dB (p < 0.05). In the control group, our results showed similar improvement in BCVA and CPT values at the 12-month follow-up (from 0.59 ± 0.12 to 0.72 ± 0.23 and from 424.17 ± 68.12 µm to 387.51 ± 93.45 µm, respectively, p < 0.05). The RS value, on the contrary, decreased from 12.32 ± 0.90 dB to 10.14 ± 0.71 dB (p < 0.05). Conclusions. The combined laser technology is a safe treatment technique that allows to minimise the extent of laser-induced chorioretinal complex damage due to the contribution of subthreshold micropulse laser photocoagulation. The efficacy of this novel technology is comparable with that of the mETDRS technique in the resolution of macular oedema and BCVA increase. This technology also provides an advantage of RS improvement and the possibility of safe and repetitive treatment sessions.Aleksander Victorovich DogaGalina Fedorovna KachalinaElena Konstantinovna PedanovaDmitry Anatolievich BuryakovEndocrinology Research Centrearticlesubthreshold micropulse yellow laser photocoagulationretinal pigment epitheliumlaser photocoagulationoptical coherence tomographyautofluorescencemicroperimetryNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 1, Pp 68-74 (2017)
institution DOAJ
collection DOAJ
language EN
RU
topic subthreshold micropulse yellow laser photocoagulation
retinal pigment epithelium
laser photocoagulation
optical coherence tomography
autofluorescence
microperimetry
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle subthreshold micropulse yellow laser photocoagulation
retinal pigment epithelium
laser photocoagulation
optical coherence tomography
autofluorescence
microperimetry
Nutritional diseases. Deficiency diseases
RC620-627
Aleksander Victorovich Doga
Galina Fedorovna Kachalina
Elena Konstantinovna Pedanova
Dmitry Anatolievich Buryakov
Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
description Aim. To evaluate the efficacy and safety of the novel combined laser treatment technology compared with those of the conventional laser photocoagulation in diabetic macular oedema management. Material and methods. Fifty eyes of 44 patients with clinically significant diabetic macular oedema were enrolled. Patients of the main group (25 eyes) underwent combined laser treatment, whereas patients in the control group (25 eyes) underwent modified ETDRS (mETDRS) focal/grid photocoagulation. Results. Mean central point thickness (CPT) in the main group decreased from 411.24 ± 126 µm to 359.86 ± 120.4 µm (p < 0.05), with a subsequent increase in the mean best-corrected visual acuity (BCVA) from 0.52 ± 0.2 at baseline to 0.71 ± 0.2 (p < 0.05) at the 12-month follow-up. The mean central retinal sensitivity (RS) improved from 11.27 ± 3.8 dB to 13.24 ± 3.2 dB (p < 0.05). In the control group, our results showed similar improvement in BCVA and CPT values at the 12-month follow-up (from 0.59 ± 0.12 to 0.72 ± 0.23 and from 424.17 ± 68.12 µm to 387.51 ± 93.45 µm, respectively, p < 0.05). The RS value, on the contrary, decreased from 12.32 ± 0.90 dB to 10.14 ± 0.71 dB (p < 0.05). Conclusions. The combined laser technology is a safe treatment technique that allows to minimise the extent of laser-induced chorioretinal complex damage due to the contribution of subthreshold micropulse laser photocoagulation. The efficacy of this novel technology is comparable with that of the mETDRS technique in the resolution of macular oedema and BCVA increase. This technology also provides an advantage of RS improvement and the possibility of safe and repetitive treatment sessions.
format article
author Aleksander Victorovich Doga
Galina Fedorovna Kachalina
Elena Konstantinovna Pedanova
Dmitry Anatolievich Buryakov
author_facet Aleksander Victorovich Doga
Galina Fedorovna Kachalina
Elena Konstantinovna Pedanova
Dmitry Anatolievich Buryakov
author_sort Aleksander Victorovich Doga
title Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
title_short Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
title_full Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
title_fullStr Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
title_full_unstemmed Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
title_sort comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
publisher Endocrinology Research Centre
publishDate 2017
url https://doaj.org/article/ddec57eac97a47c58a35e8caabf57d19
work_keys_str_mv AT aleksandervictorovichdoga comparisonofefficacyandsafetyofthecombinedlasertreatmenttechnologyversusconventionallaserphotocoagulationindiabeticmacularedemamanagement
AT galinafedorovnakachalina comparisonofefficacyandsafetyofthecombinedlasertreatmenttechnologyversusconventionallaserphotocoagulationindiabeticmacularedemamanagement
AT elenakonstantinovnapedanova comparisonofefficacyandsafetyofthecombinedlasertreatmenttechnologyversusconventionallaserphotocoagulationindiabeticmacularedemamanagement
AT dmitryanatolievichburyakov comparisonofefficacyandsafetyofthecombinedlasertreatmenttechnologyversusconventionallaserphotocoagulationindiabeticmacularedemamanagement
_version_ 1718429559234232320